Quick Answer
CORCEPT THERAPEUTICS INC reported Cash And Cash Equivalents At Carrying Value of $120.50 million for the year ending 2025.
- CORCEPT THERAPEUTICS INC showed a decrease of -5.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from CORCEPT THERAPEUTICS INC's annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: $35.39 million | Q3 2010: $28.98 million | Q1 2011: $59.20 million | Q2 2011: $52.23 million | Q3 2011: $45.91 million | Q1 2012: $42.63 million | Q2 2012: $34.90 million | Q3 2012: $101.63 million | Q1 2013: $81.46 million | Q2 2013: $72.22 million | Q3 2013: $63.18 million | Q1 2014: $43.62 million | Q2 2014: $33.97 million | Q3 2014: $26.78 million | Q1 2015: $37.95 million | Q2 2015: $37.05 million | Q3 2015: $36.45 million | Q1 2016: $40.74 million | Q2 2016: $41.79 million | Q3 2016: $47.87 million | Q1 2017: $37.98 million | Q2 2017: $33.62 million | Q3 2017: $31.06 million | Q1 2018: $33.12 million | Q2 2018: $31.17 million | Q3 2018: $33.89 million | Q1 2019: $49.65 million | Q2 2019: $58.14 million | Q3 2019: $44.95 million | Q1 2020: $84.48 million | Q2 2020: $58.52 million | Q3 2020: $30.56 million | Q1 2021: $52.38 million | Q2 2021: $95.43 million | Q3 2021: $94.69 million | Q1 2022: $61.86 million | Q2 2022: $35.35 million | Q1 2023: $299.94 million | Q2 2023: $172.38 million | Q3 2023: $111.80 million | Q1 2024: $149.75 million | Q2 2024: $128.59 million | Q3 2024: $137.29 million | Q1 2025: $89.82 million | Q2 2025: $102.75 million | Q3 2025: $125.14 million.
- Over the full 18 years of available data (2008 to 2025), CORCEPT THERAPEUTICS INC's Cash And Cash Equivalents At Carrying Value has grown by 718.8%.
- Historical annual values: Fiscal year 2025: $120.50 million | Fiscal year 2024: $127.67 million | Fiscal year 2023: $135.55 million | Fiscal year 2022: $66.33 million | Fiscal year 2021: $77.62 million | Fiscal year 2020: $76.19 million | Fiscal year 2019: $31.27 million | Fiscal year 2018: $41.63 million | Fiscal year 2017: $31.06 million | Fiscal year 2016: $51.54 million | Fiscal year 2015: $40.44 million | Fiscal year 2014: $24.25 million | Fiscal year 2013: $54.88 million | Fiscal year 2012: $93.03 million | Fiscal year 2011: $39.64 million | Fiscal year 2010: $24.58 million | Fiscal year 2009: $23.87 million | Fiscal year 2008: $14.72 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: